AP-HP, Fédération des Maladies du Système Nerveux, Université Pierre et Marie Curie-Paris, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Curr Opin Neurol. 2010 Aug;23(4):420-5. doi: 10.1097/WCO.0b013e32833b7798.
This review focuses on new insights in deep brain stimulation (DBS) for patients with hyperkinetic movement disorders: dystonia, tardive dyskinesia and Gille de la Tourette's syndrome, during the last 18 months.
The recent literature confirms the efficacy of high-frequency stimulation of the globus pallidus internus (GPi) for primary dystonia, generalized or not, with a stable effect over time. The benefit of DBS in other forms of localized dystonia remains to be demonstrated in larger studies. Some clinical and radiological predictive factors have been determined with a predominant influence of the disease duration. Tardive dystonia and myoclonus-dystonia are also improved by GPi stimulation. Encouraging results obtained in cerebral palsy may pave the way for the application of DBS in other secondary dystonia. In Gilles de la Tourette's syndrome, both stimulation of the centre-median/parafascicular nucleus of the thalamus and GPi stimulation (ventromedial) have demonstrated efficacy with stable long-term effect. Thalamic stimulation failed to improve obsessions and compulsions in some patients. Stimulation of the nucleus accumbens has been tested in few cases with contradictory efficacy. In both diseases, complications are rare with no major side effects.
The few controlled studies showed that bilateral GPi stimulation is a well tolerated and a long-term effective treatment for hyperkinetic disorders. However, recent published data of DBS applied in different targets or patients (especially secondary dystonia) are mainly uncontrolled case reports, precluding the clear determination of the efficacy of this procedure and the choice of the 'good' target for the 'good' patient.
本文重点介绍了过去 18 个月里,深部脑刺激(DBS)治疗运动障碍性疾病(如肌张力障碍、迟发性运动障碍和 Gilles de la Tourette 综合征)的新进展。
近期文献证实高频刺激苍白球 internus(GPi)对原发性肌张力障碍,包括全身性或非全身性,具有稳定的长期疗效。DBS 在其他类型局限性肌张力障碍中的疗效仍需更大规模的研究来证实。一些临床和影像学预测因素已被确定,其中疾病持续时间的影响占主导地位。GPi 刺激也可改善迟发性运动障碍和肌阵挛-肌张力障碍。GPi 刺激在脑瘫患者中取得的令人鼓舞的结果可能为 DBS 在其他继发性肌张力障碍中的应用铺平道路。在 Gilles de la Tourette 综合征中,丘脑中央中/旁正中核刺激和 GPi 刺激(腹内侧)均显示出疗效,且长期效果稳定。在一些患者中,丘脑刺激未能改善强迫观念和强迫行为。在少数病例中,已对伏隔核刺激进行了测试,但疗效存在争议。在这两种疾病中,并发症罕见,且无重大副作用。
为数不多的对照研究表明,双侧 GPi 刺激是一种耐受性良好且长期有效的治疗运动障碍性疾病的方法。然而,最近发表的关于 DBS 应用于不同靶点或患者(尤其是继发性肌张力障碍)的研究数据主要是未经对照的病例报告,无法明确确定该手术的疗效以及选择“好”靶点和“好”患者。